Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer
NCT04145960 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2019-11-18
Summary
The relationship between immune inflammation-related protein complexes in blood and recurrence or metastasis of breast cancer will be studied.
Conditions
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Principal Investigators
-
Yali Xu
Eligibility
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-25
- Primary Completion
- 2020-03-31
- Completion
- 2025-03-31
Countries
- China
Study Locations
More Related Trials
-
IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer
NCT01543126 ·Status: TERMINATED
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer
NCT05767931 ·Status: UNKNOWN
-
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
NCT03047889 ·Status: UNKNOWN
-
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
NCT00355316 ·Status: COMPLETED ·Phase: NA
-
Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR
NCT03947736 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN
-
Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women
NCT04996615 ·Status: UNKNOWN
-
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
NCT04925856 ·Status: RECRUITING ·Phase: NA
-
The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.
NCT04360616 ·Status: UNKNOWN
-
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
NCT06718010 ·Status: RECRUITING
-
99mTc-ABH2 SPECT/CT in Breast Cancer
NCT06194565 ·Status: RECRUITING ·Phase: NA
-
Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT05468710 ·Status: UNKNOWN
-
The Study on the Clinical Utility of Liquid Biopsy in Breast Cancer
NCT02902991 ·Status: UNKNOWN
-
Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
NCT01140776 ·Status: TERMINATED
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN
-
Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer
NCT07154563 ·Status: RECRUITING
-
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
NCT00463034 ·Status: UNKNOWN
-
Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer
NCT04065321 ·Status: RECRUITING
-
Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca
NCT00756132 ·Status: COMPLETED
-
Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer
NCT05982626 ·Status: RECRUITING ·Phase: NA
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
NCT05804578 ·Status: RECRUITING
-
Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study
NCT05444647 ·Status: UNKNOWN